Treating amyloid transthyretin cardiomyopathy: lessons learned from clinical trials

An increasing awareness of the disease, new diagnostic tools and novel therapeutic opportunities have dramatically changed the management of patients with amyloid transthyretin cardiomyopathy (ATTR-CM). Supportive therapies have shown limited benefits, mostly related to diuretics for the relief from...

Descripción completa

Detalles Bibliográficos
Autores principales: Tomasoni, Daniela, Bonfioli, Giovanni Battista, Aimo, Alberto, Adamo, Marianna, Canepa, Marco, Inciardi, Riccardo M., Lombardi, Carlo Mario, Nardi, Matilde, Pagnesi, Matteo, Riccardi, Mauro, Vergaro, Giuseppe, Vizzardi, Enrico, Emdin, Michele, Metra, Marco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Cardiovascular Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242061/
https://www.ncbi.nlm.nih.gov/pubmed/37288260
http://dx.doi.org/10.3389/fcvm.2023.1154594

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242061/
https://www.ncbi.nlm.nih.gov/pubmed/37288260
http://dx.doi.org/10.3389/fcvm.2023.1154594

Ejemplares similares